Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies
<i>Background and Aims</i>: Statins are the first-line medication to treating hypercholesterolemia. Several studies have investigated the impact of statins on the risk of hepatocellular carcinoma (HCC). However, the extent to which statins may prevent HCC remains uncertain. Therefore, we...
Main Authors: | Md. Mohaimenul Islam, Tahmina Nasrin Poly, Bruno Andreas Walther, Hsuan-Chia Yang, Yu-Chuan (Jack) Li |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/3/671 |
Similar Items
-
Hepatocellular Carcinoma-Liver Resections
by: Sefa Tüzün, et al.
Published: (2015-03-01) -
Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
by: Jae Seung Lee, et al.
Published: (2021-09-01) -
Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?
by: A.L. Chagas, et al. -
Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?
by: A.L. Chagas, et al.
Published: (2009-10-01) -
Kallistatin, a new and reliable biomarker for the diagnosis of liver cirrhosis
by: Zhiyun Cheng, et al.
Published: (2015-05-01)